Clinical Trial: Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen

U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07215936) titled 'Dose-dense Capecitabine Schedule [7days on _7 Days Off] in Colorectal Cancer in Comparison With Standered Regimen' on Oct. 04.

Brief Summary: Dose\_dense Capecitabine Schedule in colorectal cancers

Study Start Date: Sept. 25

Study Type: INTERVENTIONAL

Condition: Colorectal Cancer

Intervention: DRUG: Arm A:Dose_dense Capecitabine in Colorectal cancer

Appling dose \_dense Capecitabine 1750mg/m2 for one week then one week off Cycle repeated every 2 weeks

DRUG: Arm B : standard dose Capecitabine

Pateints will receive capecitabine 1000 mg/m2 for 2 weeks then one week off

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Sohag...